メタボトロピックGABA受容体の活性化の構造的基礎
Hamidreza Shaye1,2, Andrii Ishchenko1,2, Jordy Homing Lam1,3
1Bridge Institute, USC Michelson Center for Convergent Biosciences, University of Southern California, Los Angeles, CA, USA.
Nature
|June 20, 2020
まとめ
研究者らは,メタボトロプ的 γ-アミノバター酸受容体 (GABAB) の不活性状態と活性状態を,冷凍EMを用いて視覚化した. この構造は,アゴニスト結合およびアロステリック調節体がGABAB受容体のシグナル伝達をどのように制御するかを明らかにする.
科学分野:
- 神経科学
- 構造生物学
- 生物化学
背景:
- メタボトロピックγ-アミノバター酸受容体 (GABAB) は,中枢神経系におけるシナプス活動の調節に不可欠である.
- GABAB受容体の機能障害は,中毒や精神病などの神経心理学的障害と関連しています.
- GABAB受容体は,Gタンパク質結合受容体 (GPCR) で,Cクラスに属し,義務性GB1-GB2ヘテロダイマーとして機能する.
研究 の 目的:
- GABAB受容体の活性化に伴う構造的メカニズムを解明する.
- リガンド結合時のGB1-GB2ヘテロダイマーの構成変化を視覚化する.
- 活性受容体状態の安定化における陽性アロステル変調剤の役割についての洞察を提供すること.
主な方法:
- 高解像度構造を決定するために,冷凍電子顕微鏡 (cryo-EM) が使用されました.
- 人間の全長型GB1- GB2ヘテロダイマーの4つの異なる構造状態が解消されました.
- 構造には,不活性なアポ状態,中間アゴニスト結合状態,アゴニストと陽性アロステリック調節器を持つ活性状態が含まれていた.
主要な成果:
- アゴニストの結合は,GB1サブユニットにおけるヴェーナス・フライトラップ領域の閉鎖を誘導する.
- これはコンフォメーションの移行を開始し,トランスメブラン領域を密接に結びつけます.
- GB2トランスメブランドメインを含むレバーのようなメカニズムは下流信号伝達を媒介する.
- 陽性アロステリック調節剤は,トランスメブラン界面に結合することによって,活性受容体の形状を安定させる.
結論:
- この研究は,GABAB受容体の活性化を制御する動的形状の変化を明らかにした.
- この発見は,リガンドが受容体の機能を調節する複雑なメカニズムを明らかにしています.
- 構造的な洞察は神経学的および精神学的状態のための標的治療法の開発に道を開きます.
さらに関連する動画
関連する概念動画
Activation and Inactivation of G Proteins
10.2K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
10.2K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.5K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.5K
GPCRs Regulate Adenylyl Cylase Activity
7.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.0K
G-Protein Gated Ion Channels
5.4K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
5.4K
Transducer Mechanism: G Protein–Coupled Receptors
3.6K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.6K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K


